Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia in AustraliaAvecho to receive ...
CoreWeave, the AI Hyperscalertm, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback